NuVasive®, Inc.
A
A

Executive Leadership

Gregory T. Lucier, Chairman of the Board and Chief Executive Officer

Gregory T. Lucier

Chairman of the Board and Chief Executive Officer

Gregory T. Lucier has served as our Chairman and Chief Executive Officer since May 2015  He has served as a member of the NuVasive Board of Directors since December 2013.  From May 2003 to February 2014, Mr. Lucier served as Chairman and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014.  During Mr. Lucier’s 11-year tenure at Life Technologies, he led the company from a small start-up known as Invitrogen in 2003, directed the acquisition and merger of Invitrogen with Applied Biosystems in 2008 into the renamed Life Technologies, and then transformed the organization by 2013 into a global, world-leading biotechnology firm with 50,000 products, 12,000 employees and nearly $4 billion in sales in more than 180 countries.  Serving in his leadership role, Mr. Lucier was responsible for fostering a culture of excellence and applied his more than 25 years of strategic management experience to deliver industry-leading operating margins, double-digit compounded annual growth in earnings per share and significant free cash flow.  Mr. Lucier previously was a Corporate Officer of General Electric and served as an executive at GE Medical Systems.  He received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School.  In addition to serving on the Board of NuVasive, Mr. Lucier serves as the Board Chairman for Sanford Burnham Medical Research Institute, is a member of the Catalent, Inc. Board of Directors and is a former director of CareFusion Corporation, now part of Becton, Dickinson & Co.

Patrick Miles, President and Chief Operating Officer

Patrick Miles

President and Chief Operating Officer

Patrick Miles has served as our President and Chief Operating Officer since February 2015 and is responsible for leadership and management of NuVasive’s global products and services, as well as operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering.  Prior to that, he served as our President of Global Products and Services from October 2011 to January 2015, President of the Americas from January 2010 to September 2011, Executive Vice President of Product Marketing and Development from January 2007 to December 2009, as our Senior Vice President of Marketing from December 2004 to January 2007, and as our Vice President, Marketing from January 2001 to December 2004. Mr. Miles has more than 20 years of experience in the orthopaedic industry. He served as Director of Marketing for ORATEC Interventions, Inc., a medical device company, and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek. Prior to that, he held several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

Matt Link,  President,  U.S. Commercial

Matt Link

President, U.S. Commercial

Matt Link has served as our President, U.S. Commercial since July 2015 and is responsible for driving greater sales force efficiencies and the further development of NuVasive’s commercial strategies, including broad efforts to integrate the Company’s sales, service and specialized customer marketing programs.  Previously, he served as our President, U.S. Sales and Service responsible for the leadership of all U.S. field personnel under NuVasive’s combined sales and service organization structure, which includes the management of the Company’s field sales, clinical associates, neurophysiologists and monitoring contracting. Prior to that, Mr. Link served as our Executive Vice President of U.S. Sales from January 2013 to January 2015 and Senior Vice President of Sales for the Company’s U.S. Eastern region from January 2012 to December 2012. Mr. Link joined NuVasive in 2006 and has more than 12 years in the healthcare industry serving in several regional sales positions with DePuy Orthopedics and DePuy Spine. Mr. Link received a BSEd in Physical Education and Sports Medicine from the University of Virginia.

Quentin Blackford, Executive Vice President and Chief Financial Officer

Quentin Blackford

Executive Vice President and Chief Financial Officer

Quentin Blackford has served as our Chief Financial Officer since August 2014. Prior to that he served as Executive Vice President of Finance and Investor Relations since July 2012, and previously served as Vice President, Finance from January 2011.  Mr. Blackford joined NuVasive in 2009 as our Corporate Controller and has more than 10 years of experience in the healthcare industry, including his time at Zimmer Holdings, Inc. where he held various roles and responsibilities, including the Director of Finance & Controller for Zimmer’s Dental Division where he was responsible for all finance, accounting and IT activities for the worldwide division.  Prior to that he was responsible for the global corporate financial planning and analysis function.  Mr. Blackford is a Certified Public Accountant and obtained Bachelor of Science degrees in both Accounting and Business Administration from Grace College.

Jason M. Hannon, Executive Vice President, International and General Counsel

Jason M. Hannon

Executive Vice President, International and General Counsel

Jason M. Hannon has served as our Executive Vice President, International and General Counsel since July 2015 and is responsible for NuVasive’s business and commercial operations outside of the United States, including leading the Company’s international expansion opportunities. As General Counsel, Mr. Hannon is also responsible for all legal matters pertaining to the company, including corporate and strategic transactions, litigation, risk management, etc. Prior to that, Mr. Hannon served as NuVasive’s Executive Vice President, Corporate Development and General Counsel since January 2010 and previously was our Senior Vice President, Corporate Development and General Counsel. He has been with NuVasive since 2005. Mr. Hannon’s background includes the practice of corporate and transactional law, specializing in mergers and acquisitions, public and private financing, joint ventures, licensing arrangements and corporate governance matters, with the law firms of Brobeck Phleger & Harrison LLP and Heller Ehrman LLP. Mr. Hannon received a B.A. from the University of California, Berkeley, and a J.D. from Stanford Law School.

Carol Cox, Executive Vice President, Strategy, Corporate Development & External Affairs

Carol Cox

Executive Vice President, Strategy, Corporate Development & External Affairs

Carol Cox has served as our Executive Vice President, Strategy, Corporate Development & External Affairs since July 2015 and is responsible for leading NuVasive’s corporate development and mergers and acquisitions strategy, leveraging the Company’s communications, investor relations and government affairs channels in support of its strategic priorities, and creating a corporate marketing and brand team. Ms. Cox has more than 20 years of senior level experience in cross-functional corporate roles in the healthcare sector. Previously, she served as NuVasive’s Executive Vice President, Corporate Affairs and Human Resources since December 2014 and prior to that she served as the Company’s Executive Vice President, Strategy and Corporate Communications. Ms. Cox joined NuVasive in July 2014 from Sanford-Burnham Medical Research Institute (Sanford-Burnham) where she served as Senior Vice President, External Affairs, leading external and internal communications, philanthropy, marketing, government relations and efforts to elevate the Institute’s global recognition. Prior to Sanford- Burnham, she served as Senior Vice President of External Affairs and Corporate Communications at Life Technologies, where she spearheaded global strategies to drive awareness of the company’s major initiatives, enhance its global brand, and maintain its corporate reputation across multiple stakeholder groups including shareholders, the media, government officials, customers and the communities. Before joining Life Technologies, Ms. Cox was Vice President of Investor Relations at CareFusion Corporation and Senior Vice President for Global Corporate Communications and Investor Relations at Barr Pharmaceuticals, where her team received multiple awards from Institutional Investor magazine for outstanding performance. She holds a bachelor’s of arts degree in Foreign Affairs from the University of Virginia and a certificate in Investor Relations from The University of Connecticut School of Business.

Pete Leddy, Ph.D., Executive Vice President, Human Resources & Corporate Integrity

Pete Leddy, Ph.D.

Executive Vice President, Human Resources & Corporate Integrity

Pete Leddy, Ph.D., has served as our Executive Vice President, Human Resources & Corporate Integrity since July 2015 and is responsible for leadership of the NuVasive’s Human Resources, Compliance, Regulatory and Facilities departments after serving as a member of the Company’s Board of Directors from 2011 to July 2015.  Dr. Leddy’s success in driving business growth through the application of best-in-class, innovative Human Resource solutions has resulted in his leading several major employee and cultural transformation initiatives throughout his more than 25 year career. Most recently, he served as Chief Human Resource Officer at Taylor Made Golf Company.  From 2005 to February 2014, Dr. Leddy served as Chief Human Resources Officer at Life Technologies, a biotechnology company. During his tenure at Life Technologies, Dr. Leddy developed a premier human resources function, aligning business strategy to business growth for 10,000 employees at over 80 sites worldwide.  Prior to Life Technologies, Dr. Leddy held several senior management positions with Dell Incorporated, from 2000 to 2005, where he was responsible for leading global talent and human resources in the Americas, overseeing 12,000 employees.  He has served as the Executive Vice President for Human Resources at Promus Hotel Corporation (Doubletree, Embassy Suites), implementing human resources strategies that drove operational excellence with 350 HR professionals in every level of the company. In addition, he has held a variety of executive and human resource positions at PepsiCo.  Dr. Leddy currently serves on the board of directors of Pathway Genomics Corporation. He received his B.A. in Psychology from Creighton University and his M.S. and Ph.D. degrees in industrial/organizational psychology from the Illinois Institute of Technology.

Russell Powers, Executive Vice President

Russell Powers

Executive Vice President

Russell Powers has served as an Executive Vice President at NuVasive since July 2015 and is focused on the Company’s expansion into greater China.  Prior to that, Mr. Powers served as the Executive Vice President, International.  He also served as NuVasive’s Senior Vice President of Operations and Senior Vice President of Spine & Biologics, leading Marketing, Product Development and International for ThoracoLumbar, Cervical and Biologics. He was also Vice President of Reimbursement for NuVasive. With over 20 years of orthopaedic and spine experience, Mr. Powers joined NuVasive after a 13-year-career with Medtronic Spinal & Biologics in which he held various leadership positions in Marketing, Sales, and International. He was Vice President, International for Medtronic Spinal & Biologics and International Vice President, Medtronic. He served on the Executive Council and International Leadership Team, and was a Member of the Board for the Medtronic/Weigao Joint Venture. Mr. Powers began his career in orthopaedics with Smith & Nephew as a member of the Trauma Marketing team. He holds a B.B.A. from the University of Memphis.